 |
|
|
| |
EFFECT OF STEADY-STATE FALDAPREVIR ON THE PHARMACOKINETICS OF STEADY-STATE METHADONE AND BUPRENORPHINE/NALOXONE IN SUBJECTS ON STABLE ADDICTION MANAGEMENT THERAPY
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
D Joseph1, MJ Schobelock1, RA Riesenberg2, B Vince3, LR Webster4, A Adeniji1, M Elgadi5, F Huang11Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Atlanta Center for Medical Research, Overland Park, KS, USA; 3Vince and Associates Clinical Research, Atlanta, GA, USA; 4CRI Lifetree, Salt Lake City, UT, USA; 5Boehringer Ingelheim (Canada) Ltd/Ltée, Burlington, ON, Canada
|
| |
|
|
|
|
|
